Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Autologous BMC is safe and effective in treating patients with atrophic non-unions

Aug. 8, 2016

Omeros' lead MASP-3 inhibitor shows efficacy in arthritis model

Aug. 5, 2016

Biogen initiates phase I trial of BIIB-068 in healthy subjects

Aug. 2, 2016

EMA accepts for review MAA for sarilumab

Aug. 1, 2016

Merck & Co. discloses BTK inhibitors

Aug. 1, 2016

Merck & Co. announces BTK inhibitors

July 22, 2016

Karos Pharmaceuticals presents tryptophan hydroxylase inhibitors

July 21, 2016

Merck & Co. reports BTK inhibitors

July 21, 2016

Beta1-Integrin is a novel therapeutic target in pathological conditions of the muscle

July 19, 2016

Merck & Co. patents describe BTK inhibitors

July 19, 2016

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...